Cellectis (CLLS) Enterprise Value (2016 - 2025)
Cellectis (CLLS) has 7 years of Enterprise Value data on record, last reported at -$101.1 million in Q4 2022.
- For Q4 2022, Enterprise Value rose 45.53% year-over-year to -$101.1 million; the TTM value through Dec 2022 reached -$101.1 million, up 45.53%, while the annual FY2022 figure was -$101.1 million, 45.53% up from the prior year.
- Enterprise Value reached -$101.1 million in Q4 2022 per CLLS's latest filing, up from -$185.6 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$101.1 million in Q4 2022 and bottomed at -$451.5 million in Q4 2018.
- Average Enterprise Value over 4 years is -$244.9 million, with a median of -$213.4 million recorded in 2020.
- Peak YoY movement for Enterprise Value: tumbled 52.03% in 2018, then surged 45.53% in 2022.
- A 4-year view of Enterprise Value shows it stood at -$451.5 million in 2018, then soared by 46.59% to -$241.1 million in 2020, then rose by 23.02% to -$185.6 million in 2021, then surged by 45.53% to -$101.1 million in 2022.
- Per Business Quant database, its latest 3 readings for Enterprise Value were -$101.1 million in Q4 2022, -$185.6 million in Q4 2021, and -$241.1 million in Q4 2020.